Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

HLA Class I Alloimmunization and Platelet Transfusion Support in HLA-Identical Bone Marrow Transplant for Sickle Cell Disease: A Sickle Transplant Alliance for Research Study

Robert Sheppard Nickel, MD MSc, John T. Horan, MD MPH, Allistair Abraham, MD, Muna Qayed, MD MSc, Ann Haight, MD, Naomi Luban, MD, Jeanne E. Hendrickson, MD

Blood (2018) 132 (Supplement 1): 3816.

https://doi.org/10.1182/blood-2018-99-114116

Published: 2018

Journal Articles

Similar Event-Free Survival but Higher Incidence of Mixed T Cell Chimerism after Hematopoietic Cell Transplantation for Sickle Cell Disease Using Rabbit Versus Horse ATG: a Study from the Sickle Transplant Alliance for Research (STAR)

Allistair Abraham, MD, Elizabeth Stenger, MD, Curtis D Travers, MPH, Robert Nickel, MDMSc, Hemalatha G. Rangarajan, MD, Jennifer Krajewski, MD, Sonali Chaudhury, MBBS,MD, Kimberly A. Kasow, DO, Troy C. Quigg, DO, Alexander I. Ngwube, MD, Jennifer Jaroscak, MD, Gregory M Guilcher, MDBSc,FRCPC, Shalini Shenoy, MD, John T Horan, MD

Blood (2017) 130 (Supplement 1): 3535.

https://doi.org/10.1182/blood.V130.Suppl_1.3535.3535

Published: 2017

Journal Articles

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

Blood (2017) 130 (Supplement 1): 212.

https://doi.org/10.1182/blood.V130.Suppl_1.212.212

Published: 2017

Journal Articles

Efficacy of ALL Therapy for WHO2016-Defined Mixed Phenotype Acute Leukemia: A Report from the Children's Oncology Group

Etan Orgel, MD MS, Thomas B. Alexander, MDMPH, Brent Wood, MDPhD, Samir Kahwash, MD, Meenakshi Devidas, Yunfeng Dai, PhD, Todd A Alonzo, PhD, Charles G. Mullighan, MBBS, MD, Hiroto Inaba, MD, Stephen P. Hunger, MD, Alan S Gamis, MD MPH, Andrew J. Carroll, III, PhD, Nyla A. Heerema, PhD, Jason Berman, MD, William G Woods, MD, Mignon L. Loh, MD, Patrick A. Zweidler-McKay, MDPhD, John T Horan, MD

Blood (2017) 130 (Supplement 1): 883.

https://doi.org/10.1182/blood.V130.Suppl_1.883.883

Published: 2017

Journal Articles

Isolated Myeloperoxidase Expression in Pediatric B/Myeloid Mixed Phenotype Acute Leukemia Is Associated with Improved Survival Using ALL-Only Regimens

Sunil S Raikar, MD, Sunita Park, MD, Traci Leong, PhD, David L Jaye, MD, Frank G Keller, MD, John T Horan, MD, William G Woods, MD

Blood (2017) 130 (Supplement 1): 1290.

https://doi.org/10.1182/blood.V130.Suppl_1.1290.1290

Published: 2017

Journal Articles

Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML) Have Increased Treatment-Related Mortality with Similar Outcomes -- a Report from the Children's Oncology Group Trials AAML03P1 and AAML0531

Keith J. August, MD MS, Richard Aplenc, MD PhD, Lillian Sung, MD PhD, Susana C. Raimondi, PhD, Betsy A. Hirsch, PhD, John T. Horan, MD MPH, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Yi-Cheng Jim Wang, MS, Samir Kahwash, MD, Amy Heerema-McKenney, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH

Blood (2014) 124 (21): 3672.

https://doi.org/10.1182/blood.V124.21.3672.3672

Published: 2014

Journal Articles

Improved Splenic Function after Stem Cell Transplant for Sickle Cell Disease

Robert Sheppard Nickel, MD, Elizabeth Seashore, MD, Adina L. Alazraki, MD, John T. Horan, MD MPH, Monica Bhatia, MD, Ann E. Haight, MD

Blood (2014) 124 (21): 3966.

https://doi.org/10.1182/blood.V124.21.3966.3966

Published: 2014

Journal Articles

Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease

Robert S. Nickel, MD, Jeanne E. Hendrickson, MD, John T. Horan, MD, MPH, Aneesah P. Garrett, Jennifer M. Robertson, PhD, Ifeyinwa Osunkwo, MD, MPH, Leslie S. Kean, MD, PhD

Blood (2013) 122 (21): 2208.

https://doi.org/10.1182/blood.V122.21.2208.2208

Published: 2013

Journal Articles

Expression Of CD36 and The Presence Of Cytoplasmic Granules In Blasts Predicts Poor Prognosis In Children With B-Lymphoblastic Leukemia

Joanna G Newton, MD, John T. Horan, MD, MPH, Sunita Park, MD

Blood (2013) 122 (21): 4947.

https://doi.org/10.1182/blood.V122.21.4947.4947

Published: 2013

Journal Articles

Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease

Robert S. Nickel, MD, Jeanne E. Hendrickson, MD, Leslie S. Kean, MD, PhD, Marianne E. McPherson Yee, MD, MSc, Robert A. Bray, PhD, Howard M. Gebel, PhD, David B. Miklos, MD, PhD, John T. Horan, MD, MPH

Blood (2013) 122 (21): 39.

https://doi.org/10.1182/blood.V122.21.39.39

Published: 2013

Journal Articles

Impact Of Residual Disease On Survival In Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation For Acute Myeloid Leukemia In First Complete Remission

John T. Horan, MD, MPH, Soheil Meshinchi, MD, PhD, Michael R. Loken, PhD, Todd A. Alonzo, PhD, Richard Aplenc, MD, Stella M. Davies, MBBS, PhD, Robert B. Gerbing, MA, Alan S. Gamis, MD, MPH

Blood (2013) 122 (21): 65.

https://doi.org/10.1182/blood.V122.21.65.65

Published: 2013

Journal Articles

Transfusion of Leukoreduced RBC Results in Immunization to Minor Histocompatibility Antigens by Crosspriming into Recipient MHC Class I Pathways.

James C. Zimring, MD, PhD, Gregory A. Hair, PhD, Seema S. Deshpande, PhD, John T. Horan, MD

Blood (2005) 106 (11): 1266.

https://doi.org/10.1182/blood.V106.11.1266.1266

Published: 2005

Journal Articles

Prophylactic Colony-Stimulating Factors in Pediatric Patients Receiving Myelosuppressive Chemotherapy: A Meta-Analysis of Randomized Controlled Trials.

Brenda Wittman, MD, John T. Horan, MD, MPH, Gary H. Lyman, MD, MPH

Blood (2004) 104 (11): 2211.

https://doi.org/10.1182/blood.V104.11.2211.2211

Published: 2004

NARROW

HLA Class I Alloimmunization and Platelet Transfusion Support in HLA-Identical Bone Marrow Transplant for Sickle Cell Disease: A Sickle Transplant Alliance for Research Study

Similar Event-Free Survival but Higher Incidence of Mixed T Cell Chimerism after Hematopoietic Cell Transplantation for Sickle Cell Disease Using Rabbit Versus Horse ATG: a Study from the Sickle Transplant Alliance for Research (STAR)

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

Efficacy of ALL Therapy for WHO2016-Defined Mixed Phenotype Acute Leukemia: A Report from the Children's Oncology Group

Isolated Myeloperoxidase Expression in Pediatric B/Myeloid Mixed Phenotype Acute Leukemia Is Associated with Improved Survival Using ALL-Only Regimens

Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML) Have Increased Treatment-Related Mortality with Similar Outcomes -- a Report from the Children's Oncology Group Trials AAML03P1 and AAML0531

Improved Splenic Function after Stem Cell Transplant for Sickle Cell Disease

Alterations In Specific Immune Cell Subsets In Children With Sickle Cell Disease

Expression Of CD36 and The Presence Of Cytoplasmic Granules In Blasts Predicts Poor Prognosis In Children With B-Lymphoblastic Leukemia

Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease

Impact Of Residual Disease On Survival In Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation For Acute Myeloid Leukemia In First Complete Remission

Transfusion of Leukoreduced RBC Results in Immunization to Minor Histocompatibility Antigens by Crosspriming into Recipient MHC Class I Pathways.

Prophylactic Colony-Stimulating Factors in Pediatric Patients Receiving Myelosuppressive Chemotherapy: A Meta-Analysis of Randomized Controlled Trials.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only